These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26008868)

  • 1. 5'-Methylene-triazole-substituted-aminoribosyl uridines as MraY inhibitors: synthesis, biological evaluation and molecular modeling.
    Fer MJ; Bouhss A; Patrão M; Le Corre L; Pietrancosta N; Amoroso A; Joris B; Mengin-Lecreulx D; Calvet-Vitale S; Gravier-Pelletier C
    Org Biomol Chem; 2015 Jul; 13(26):7193-222. PubMed ID: 26008868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward analogues of MraY natural inhibitors: synthesis of 5'-triazole-substituted-aminoribosyl uridines through a Cu-catalyzed azide-alkyne cycloaddition.
    Fer MJ; Olatunji S; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    J Org Chem; 2013 Oct; 78(20):10088-105. PubMed ID: 24044436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial transferase MraY inhibitors: synthesis and biological evaluation.
    Lecerclé D; Clouet A; Al-Dabbagh B; Crouvoisier M; Bouhss A; Gravier-Pelletier C; Le Merrer Y
    Bioorg Med Chem; 2010 Jun; 18(12):4560-9. PubMed ID: 20537545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and molecular modeling of urea-containing MraY inhibitors.
    Oliver M; Le Corre L; Poinsot M; Corio A; Madegard L; Bosco M; Amoroso A; Joris B; Auger R; Touzé T; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Org Biomol Chem; 2021 Jul; 19(26):5844-5866. PubMed ID: 34115086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.
    Dini C; Collette P; Drochon N; Guillot JC; Lemoine G; Mauvais P; Aszodi J
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1839-43. PubMed ID: 10969981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Sub-Micromolar MraY
    Oliver M; Le Corre L; Poinsot M; Bosco M; Wan H; Amoroso A; Joris B; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.
    Mihalyi A; Jamshidi S; Slikas J; Bugg TD
    Bioorg Med Chem; 2014 Sep; 22(17):4566-71. PubMed ID: 25127465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of potential new inhibitors of the bacterial transferase MraY with a β-ketophosphonate structure.
    Auberger N; Frlan R; Al-Dabbagh B; Bouhss A; Crouvoisier M; Gravier-Pelletier C; Le Merrer Y
    Org Biomol Chem; 2011 Dec; 9(24):8301-12. PubMed ID: 22042341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
    Tanino T; Al-Dabbagh B; Mengin-Lecreulx D; Bouhss A; Oyama H; Ichikawa S; Matsuda A
    J Med Chem; 2011 Dec; 54(24):8421-39. PubMed ID: 22085339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial Transferase MraY, a Source of Inspiration towards New Antibiotics.
    Fer MJ; Corre LL; Pietrancosta N; Evrard-Todeschi N; Olatunji S; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Curr Med Chem; 2018; 25(42):6013-6029. PubMed ID: 29600753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise synthesis and antibacterial evaluation of novel 3-(1,4-disubstituted-1,2,3-triazolyl)uridine nucleosides.
    Tachallait H; Bouyahya A; Talha A; Bakri Y; Dakka N; Demange L; Benhida R; Bougrin K
    Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800204. PubMed ID: 30276854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
    Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
    Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
    Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of Various 5'-Deoxy-5'-(4-Substituted-1,2,3-Triazol-1-yl)-Uridine Analogues as Inhibitors of
    Hervin V; Arora R; Rani J; Ramchandran S; Bajpai U; Agrofoglio LA; Roy V
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33114668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological screening and molecular modeling studies of novel 3-chloro-4-substituted-1-(2-(1H-benzimidazol-2-yl)phenyl))-azetidin-2-ones.
    Chhajed SS; Upasani CD
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):504-8. PubMed ID: 21823835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.
    Kwak SH; Lim WY; Hao A; Mashalidis EH; Kwon DY; Jeong P; Kim MJ; Lee SY; Hong J
    Eur J Med Chem; 2021 Apr; 215():113272. PubMed ID: 33607457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and antimicrobial activities of thiouracil derivatives containing triazolo-thiadiazole as SecA inhibitors.
    Cui P; Li X; Zhu M; Wang B; Liu J; Chen H
    Eur J Med Chem; 2017 Feb; 127():159-165. PubMed ID: 28039774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors.
    Mravljak J; Monasson O; Al-Dabbagh B; Crouvoisier M; Bouhss A; Gravier-Pelletier C; Le Merrer Y
    Eur J Med Chem; 2011 May; 46(5):1582-92. PubMed ID: 21377772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of triazolyl-substituted benzyloxyacetohydroxamic acids as LpxC inhibitors.
    Hoff K; Mielniczuk S; Agoglitta O; Iorio MT; Caldara M; Bülbül EF; Melesina J; Sippl W; Holl R
    Bioorg Med Chem; 2020 Jul; 28(13):115529. PubMed ID: 32386952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action.
    Artola M; Ruiz-Avila LB; Vergoñós A; Huecas S; Araujo-Bazán L; Martín-Fontecha M; Vázquez-Villa H; Turrado C; Ramírez-Aportela E; Hoegl A; Nodwell M; Barasoain I; Chacón P; Sieber SA; Andreu JM; López-Rodríguez ML
    ACS Chem Biol; 2015 Mar; 10(3):834-43. PubMed ID: 25486266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.